The serine/threonine kinase LKB1 is a tumor suppressor whose loss is associated with increased metastatic potential. In an effort to define biochemical signatures of metastasis associated with LKB1 loss, we discovered that the epithelial-to-mesenchymal transition transcription factor Snail1 was uniquely upregulated upon LKB1 deficiency across cell types. The ability of LKB1 to suppress Snail1 levels was independent of AMPK but required the related kinases MARK1 and MARK4. In a screen for substrates of these kinases involved in Snail regulation, we identified the scaffolding protein DIXDC1. Similar to loss of LKB1, DIXDC1 depletion results in upregulation of Snail1 in a FAK-dependent manner, leading to increased cell invasion. MARK1 phosphorylation of DIXDC1 is required for its localization to focal adhesions and ability to suppress metastasis in mice. DIXDC1 is frequently downregulated in human cancers, which correlates with poor survival. This study defines an AMPK-independent phosphorylation cascade essential for LKB1-dependent control of metastatic behavior.
INTRODUCTION
A critical question in cancer biology is the relationship between tumor-initiating mutations, including oncogenes and tumor suppressor genes, and the propensity for tumors to metastasize (Hanahan and Weinberg, 2011) . LKB1/STK11 is the causal gene inactivated in the inherited cancer disorder Peutz-Jeghers syndrome and also inactivated in $25% of non-small cell lung cancers (Ding et al., 2008) . Beyond effects on tumor initiation, loss of Lkb1 uniquely confers invasive and metastatic behavior in genetically engineered mouse models (GEMMs) of cancer when directly compared to other tumor suppressors (e.g.,
Trp53
, Rb, p16/Cdkn2a) (Carretero et al., 2010; Contreras et al., 2008; Ji et al., 2007; Liu et al., 2012) . The enhanced metastatic potential of Lkb1-deficient tumors is also notable for occurring in cancers across multiple lineages, namely endometrium, lung, and melanoma (Contreras et al., 2008; Ji et al., 2007; Liu et al., 2012) .
LKB1 is a protein kinase that through direct phosphorylation activates a family of 14 kinases related to the AMP-activated protein kinase (AMPK) (Hardie and Alessi, 2013) . Through these downstream kinases, LKB1 has highly conserved functions in organismal metabolism and cell polarity, in addition to its tumor suppressor function (Jansen et al., 2009 ). Many of the bestunderstood functions of LKB1 are attributable to its ability to activate AMPK, a central conserved regulator of metabolism and cell growth . However, LKB1 has been established as a highly conserved regulator of cell polarity as well, stemming from initial findings in Drosophila and C. elegans, where the LKB1 ortholog was identified as Partitioning-defective 4 (par-4) (Jansen et al., 2009) . In comparison to AMPK, far less is known about the biological functions and molecular targets of the other kinases activated by LKB1, though one subfamily, the microtubule affinity-regulating kinase (MARK) (or Partitioning-defective 1/Par1) genes, control apicalbasal polarity and may be primary mediators of LKB1 action in that process (Ollila and Mä kelä , 2011) .
Numerous downstream substrates of AMPK and its related kinases have been identified that provide molecular mechanisms underlying how LKB1 coordinates cell growth and metabolism (Hardie and Alessi, 2013) . For example, AMPK regulates cell growth and survival through substrates in the mammalian target of rapamycin complex 1 (mTORC1) and autophagy pathways. AMPK and related LKB1-dependent kinases coordinate cellular and organismal metabolism through phosphorylation of metabolic enzymes, glucose transport regulators, and transcriptional regulators.
Despite this insight into how LKB1 loss leads to metabolic derangement and growth of primary tumors, there are no wellestablished molecular connections between AMPK or any of its related kinases with effectors known to be involved in the control of metastasis. Moreover, it is not known whether the potent (legend continued on next page)
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metastasis suppressing activity of LKB1 is mediated by AMPK or by some of the 12 AMPK-related kinases. We report here the identification of a direct substrate of the AMPK-related kinases MARK1 and MARK4 that appears to mediate effects of LKB1 on epithelial-mesenchymal transition, migration, and metastatic behavior in vivo.
RESULTS
Snail Is Upregulated from Loss of LKB1 or Its Downstream Kinases MARK1 and MARK4, Independent of AMPK Given that LKB1 deficiency promotes aggressive metastatic behavior of diverse tumor types (Contreras et al., 2008; Ji et al., 2007; Liu et al., 2012) , we sought to identify downstream effectors of LKB1 that control metastasis. Hallmarks of the metastatic cascade include spatially restrained epithelial cells acquiring the ability to invade local tissue, intravasate, and extravasate at distant sites. Experimental evidence suggests that this cascade can be triggered by the induction of an epithelial-to-mesenchymal transition (EMT), a transcriptional program orchestrated by reexpression of conserved transcription factors critical in embryonic development (Chaffer and Weinberg, 2011) . We therefore investigated whether any EMT transcription factors were repressed by LKB1 by silencing LKB1 in a panel of LKB1-proficient tumor cell lines. Across cell lines from diverse tumor types, the transcription factor Snail1 was consistently upregulated when LKB1 was suppressed, in contrast to expression of Snail2 (Slug), ZEB1, ZEB2, or Twist ( Figure 1A ). In human NSCLC cell lines bearing LKB1 inactivation, expression of wild-type (WT) but not kinase-dead LKB1 reduced Snail1 levels ( Figure 1B ) and LKB1 knockdown in a LKB1-proficient NSCLC cell line increased Snail1 levels ( Figure 1C) . Surprisingly, the ability of LKB1 to suppress Snail1 was not confined to tumor cells or cells bearing oncogenic signals, as Lkb1 À/À mouse embryonic fibroblasts (MEFs) exhibited Snail1 upregulation compared to littermate Lkb1 +/+ MEFs ( Figure 1D ). In Lkb1-deficient NSCLC cells and MEFs, LKB1 reexpression suppressed Snail at the mRNA level (Figures S1A and S1B, available online) .
A core function of Snail family transcription factors is to create a cellular state favorable to cell migration and invasion (Thiery et al., 2009) . Snail functions through repression of the E-cadherin promoter, but also through transcriptional induction (Rembold et al., 2014) of mRNAs for extracellular matrix components, metalloproteinases, and numerous secreted growth factors, including the noncanonical Wnt ligands, Wnt5a and Wnt5b (Moreno-Bueno et al., 2006; Ren et al., 2011) . As Wnt5a mRNA is highly upregulated in Lkb1-deficient gastrointestinal polyps (Lai et al., 2011) , we examined the relationship between Wnt5a and Wnt5b levels and Snail1 levels across cell types. We found that Snail1 was necessary ( Figure S1C ) and sufficient ( Figure S1D ) for induction of Wnt5a and Wnt5b in U2OS cells. Similarly, Wnt5a/Wnt5b levels paralleled Snail protein levels in various cell types when LKB1 was silenced ( Figures 1B-1D and S1B). Moreover, elevated Wnt5a/Wnt5b in Lkb1 À/À MEFs was attenuated by knockdown of Snail1 ( Figure 1E ). Collectively, these results indicate that Snail is necessary and sufficient for Wnt5a/ Wnt5b expression in LKB1-deficient contexts, suggesting that Wnt5a/Wnt5b levels may serve here as biomarkers of Snail activity. Importantly, Snail expression was higher in lysates from lung tumors isolated from Kras LSL-G12D/+ Lkb1 L/L mice than in tumors from Kras LSL-G12D/+ Lkb1 +/+ mice, and Wnt5a/b levels paralleled elevated Snail levels here ( Figure 1F ). Since Lkb1 deficiency enhances metastatic potential in Kras LSL-G12D/+ lung tumors (Ji et al., 2007) , this is a specific context in which Snail could be mediating some of the prometastatic effects of loss of Lkb1. We therefore sought to further elucidate the molecular mechanisms by which LKB1 controls Snail levels across cell types. Because LKB1 can activate multiple AMPK-related kinases (AMPKRs), we first examined which downstream kinases controlled Snail levels. For screening purposes, we utilized U2OS cells as a human cell system in which LKB1 signaling is fully intact but can be readily suppressed by RNAi-mediated silencing of LKB1. As previously observed ( Figure 1A ), LKB1 depletion in U2OS cells resulted in elevated Snail levels, yet surprisingly combined knockdown of the two genes encoding the AMPK catalytic subunits (AMPKa1 and AMPKa2) had no effect, even though phosphorylation of the AMPK substrate acetyl-CoA carboxylase (ACC) was suppressed ( Figure 1G ). In contrast, knockdown of all four members of the MARK/Par-1 kinase subfamily resulted in Snail induction ( Figure 1G ). Knockdown of each of the MARK family members individually revealed that MARK1 (also known as Par1c) and MARK4 (Par1d) were most critical to suppression of Snail in these cells ( Figure 1H ), while the related kinases MARK2 and MARK3 had no effect on Snail levels. Deconvolution of the RNAi pools for LKB1 and MARK1 revealed that multiple independent siRNA duplexes against each target resulted in Snail induction, indicating that our observations are unlikely to be due to off-target silencing of unintended genes ( Figure S1E ).
Identification of DIXDC1 as a Substrate of MARK1 and MARK that Suppresses Snail Levels Next, we sought to further dissect the mechanism by which MARK1 and MARK4 regulate Snail levels, as very little is known about these two kinases ( Figure 1I (G) LKB1 is the master upstream activating kinase of the AMPKR kinase family. siRNA oligos targeting AMPKR subfamilies were transfected into U2OS at a final concentration of 20 mM for 72 hr. Lysates were analyzed by western blotting with the indicated antibodies.
(H) RNAi knockdown of individual MARK isoforms (20 mM) or AMPKa subunits (20 mM final) for 72 hr, followed by immunoblotting with the indicated antibodies.
(I) Pathway model. LKB1, functioning through the AMPK-related kinases MARK1 and MARK4, specifically represses the levels of the EMT transcription factor Snail1. A) Optimal phosphorylation consensus motifs were determined for all of the MARK kinases and compared to that of AMPK (Gwinn et al., 2008) . The consensus motif for MARK1 is shown. In vitro kinase assays were performed using an arrayed set of peptide mixtures in which the indicated residue was fixed at the indicated position relative to a central phosphorylation site residue. The level of phosphorylation of each peptide mixture was quantified and normalized to an average value of 1 at each position to generate the displayed heatmaps. (B) siRNA knockdown (20 mM) of known and potential MARK substrates implicated in cytoskeletal signaling that were identified in the screen. Lysates were immunoblotted for induction of Snail compared to siRNA knockdown of LKB1 and MARK1 (20 mM).
(legend continued on next page)
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identified direct substrates of AMPK based on our determination of its phosphorylation site consensus motif using arrayed positional scanning peptide libraries ( Figure S2A ) Gwinn et al., 2008; Turk et al., 2006) . To identify substrates of MARKs, we determined the substrate consensus motif for all four MARK kinases using the same method and found them to have nearly identical profiles ( Figures  2A and S2B ). The optimal in vitro peptide phosphorylation sequence for the MARK kinases (''MARK motif'') was also quite similar to our previously described AMPK motif (Gwinn et al., 2008) (Figure 2A ). This common consensus sequence includes strong preferences for aliphatic residues at positions À5 and +4 relative to the phosphorylation site, as well as for a basic residue at position À3. The similarity of these optimal sequences is consistent with previous studies demonstrating that phosphorylation sites induced by distinct members of the AMPKR family are similar in their primary sequence, and corresponds well with a survey of well-studied AMPK and MARK substrate phosphorylation sites (Shackelford and Shaw, 2009) .
We scanned the human proteome in silico to identify proteins containing sequences that matched the optimal MARK substrate motif. Repeating the search on other eukaryotic proteomes allowed us to narrow the initial list of $1,000 candidate sites in humans down to $300 highly conserved sites ( Figure S2B ). Given that control of the cytoskeleton is a major conserved function of the MARK/Par1 kinase family, we focused our attention on 25 candidate MARK substrates bearing conserved phosphorylation motifs that either contained a Pfam domain or gene ontology (GO) designation related to the cytoskeleton. As a first test of whether these 25 candidates may be regulated by MARK kinases, we examined whether exogenous gain and loss of function of MARK1 kinase activity could regulate the phosphorylation of these proteins, as measured indirectly through their binding to the phosphodependent binding scaffold protein 14-3-3 or recognition by a phosphomotif antibody generated against the optimal AMPK family substrate motif (Gwinn et al., 2008) . Many of the known substrates of AMPK, the MARKs, and their related kinases inducibly bind to 14-3-3 upon their phosphorylation by these kinases (Shackelford and Shaw, 2009 ). This screening approach revealed a handful of previously reported MARK substrates-MAP4, Par3, KIF13B, IRSp53 (see Figures S2B and S2C)-as well as four novel targets whose phosphorylation was controlled in a MARK-dependent manner (CLASP1, CLASP2, APC, DIXDC1) ( Figures S2B and S2D) .
We tested whether knockdown of the four known and four novel MARK substrates could decrease or increase basal Snail expression levels in U2OS cells. Notably, loss of the target DIXDC1 demonstrated the greatest effect, triggering an upregulation of Snail levels similar to that induced by knockdown of MARK1 or LKB1 ( Figure 2B ). Three distinct siRNA oligos targeting DIXDC1 resulted in upregulation of Snail, ruling out an offtarget effect of the siRNA pool used ( Figure S2E ). DIXDC1 (also known as CCD1) is a poorly studied scaffolding protein composed of three protein-protein interaction domains: an actin-binding calponin homology (CH) domain, a coiled-coil (CC) domain, and a disheveled and axin (DIX) oligomerization domain ( Figure 2C ). Notably, the conserved candidate MARK phosphorylation site in DIXDC1, Ser592, lies just at the start of the DIX domain ( Figure 2C ). Given that wild-type (WT), but not kinase-dead, MARK1 induced binding of DIXDC1 to 14-3-3, we examined whether the putative MARK1 phosphorylation site Ser592 was required for this association. Preventing phosphorylation by mutating Ser592 to Ala completely abolished the ability of wild-type MARK1 to induce DIXDC1 to bind 14-3-3 ( Figure S2F ). Recombinant, active MARK1 phosphorylated DIXDC1 in vitro, as judged by induced reactivity of WT, but not S529A mutant, DIXDC1 with a phosphospecific antibody raised against the site ( Figure 2D ). Similar results were observed with MARK4, demonstrating that both of these MARK kinases can phosphorylate DIXDC1 at Ser592 in vitro ( Figure S2E ). Using the phosphospecific antibody, we observed that overexpression of either WT MARK1, or LKB1 combined with its activating subunit STRADa, increased Ser592 phosphorylation of coexpressed DIXDC1 in human embryonic kidney 293T (HEK293T) cells, while kinase-inactive MARK1 was without effect ( Figure S2H ). These experiments indicate that exogenously expressed DIXDC1 can serve as a target for LKB1-and MARK1-dependent signals in cells.
To verify the endogenous kinase(s) responsible for phosphorylation of endogenous DIXDC1 at Ser592, we performed knockdown for LKB1, AMPK, and individual MARK family kinases. Silencing of LKB1, MARK1, or MARK4 resulted in loss of endogenous Ser592 DIXDC1 phosphorylation, while knockdown of AMPK, MARK2, or MARK3 had no effect ( Figure 2F ). The regulation of DIXDC1 Ser592 phosphorylation by MARK1 and MARK4 paralleled our observations that these kinases suppress Snail levels ( Figure 1H ). Furthermore, levels of phospho-Ser592 DIXDC1 were inversely correlated with the level of Snail expression ( Figure 2G ). These data suggest that the ability of DIXDC1 to suppress Snail levels may require LKB1-and MARK1/4-dependent phosphorylation of DIXDC1 Ser592. DIXDC1 knockdown also resulted in increased Wnt5a/Wnt5b, an effect that required Snail ( Figure S2I ) as previously noted in the context of LKB1 deficiency ( Figure 1E ).
(C) DIXDC1 domain structure and conservation of identified S592 residue across vertebrates. (D) In vitro IP kinase assay using recombinant active MARK1. FLAG-tagged WT or S592A DIXDC1 was expressed and immunoprecipitated from HEK293T cells. Isolated DIXDC1 was then subjected to an in vitro kinase reaction with human MARK1. Reactions were immunoblotted with a phosphospecific antibody raised against the S592 residue. Vec, empty vector. (E) MARK1 WT or KD (kinase-dead) cDNA constructs were expressed in HEK293T cells. DIXDC1 was immunoprecipitated and immunoblotted with P-DIXDC1 S592 antibody. (A) Immunolocalization of paxillin and stably expressed FLAG-DIXDC1 by lentiviral transduction in U2OS cells depleted for endogenous DIXDC1 by lentiviral shRNA transduction. Serum-starved cells were placed in suspension for 1 hr in serum-free media, followed by plating onto collagen I-coated coverslips in serumfree media for 1 hr to stimulate and synchronize focal adhesion formation. Scale bar: 10 mm (left), 2 mm (zoom image).
(B) Immunolocalization of paxillin in U2OS cells stably depleted for DIXDC1 by lentiviral shRNA transduction and plated as described in (A). A representative image is shown, and total focal adhesion number/cell is quantified on the right (n = 50 cells/condition). . DIXDC1 localized just distal to the focal adhesion protein paxillin, in a region where the focal adhesion complexes link to the intracellular actin cytoskeleton (WehrleHaller, 2012) . To determine if DIXDC1 affects focal adhesion dynamics, we examined the morphology of focal adhesions in U2OS knocked down for DIXDC1 using paxillin and zyxin as a markers for total and mature adhesions, respectively (Zaidel-Bar et al., 2003) . At 1 hr postplating, we noticed a striking contrast between mature, actin-linked adhesion plaques in control cells and an abundance of nascent, immature focal contacts in DIXDC1 shRNA cells, as judged by paxillin staining (Figures 3B and 3C) . At this time, zyxin perfectly colocalized with paxillin in control cells but was largely absent from focal contacts in DIXDC1 knockdown cells, indicating a defect in focal adhesion maturation ( Figures 3C and  3D ). Collectively, these experiments suggest that DIXDC1 controls the dynamics of focal adhesions. Importantly, knockdown for LKB1 or MARK1 in U2OS cells phenocopied the effect of DIXDC1 knockdown on focal adhesions as observed by zyxin and paxillin costaining ( Figure 3E ).
To directly examine the effect of MARK1 phosphorylation of Ser592 on DIXDC1 action at focal adhesions, we compared stable cell lines expressing FLAG-DIXDC1
WT or FLAG-DIXDC1
S592A
to cells with FLAG-DIXDC1 WT but with shRNAs to MARK1 and MARK4. Notably, nonphosphorylatable FLAG-DIXDC1
was no longer capable of localizing to focal adhesions like FLAG-DIXDC1 WT ( Figure 3F ). FLAG-DIXDC1 WT was similarly mislocalized away from focal adhesions by knockdown for MARK1 and MARK4 ( Figure 3F , right image). Collectively, these results suggest that Ser592 phosphorylation is required for the proper localization of DIXDC1 to focal adhesions.
Hyperactivation of FAK from Loss of LKB1 or DIXDC1 Function Is Responsible for Elevated Snail
As FAK is normally recruited to nascent focal adhesions concurrently with paxillin (Wehrle-Haller, 2012), and FAK was reported to be hyperactivated in LKB1-deficient lung tumors (Carretero et al., 2010) , we next examined the impact of DIXDC1 silencing on FAK. Activated Y397-phosphorylated FAK colocalized with paxillin 1 hr after plating in both nascent adhesions in the DIXDC1 or LKB1 knockdown cells as well as the larger more mature focal adhesions formed in the control cells ( Figure 4A ). Nascent adhesions are reportedly highly enriched for phosphotyrosine (ZaidelBar et al., 2003) . Consistent with this, cells bearing DIXDC1 knockdown exhibited a greater peak and prolonged activation of FAK upon plating ( Figure 4B ). The increase in FAK activation from DIXDC1 knockdown resulted in elevated Src signaling, as defined by Src Y416 phosphorylation or paxillin Y118 phosphorylation, which were both attenuated in cells expressing FAK shRNAs ( Figure 4C ) or by treatment with the small molecule FAK inhibitor PF-573228 (Slack-Davis et al., 2007) ( Figure S4A ). FAK silencing or inhibition also attenuated Snail1 induction from knockdown of DIXDC1 ( Figures 4C and 4D) , MARK1, or LKB1 ( Figure 4E ), consistent with a study reporting that FAK regulates Snail1 levels in MEFs (Li et al., 2011) . Upon DIXDC1 knockdown, FAK also exhibited increased phosphorylation at Y925, which mediates binding to Grb2 and activation of the Ras-MEK-ERK pathway. Consistent with the increased Phospho-Y925, endogenous GRB2 associated with more FAK and Src in the DIXDC1 knockdown cells ( Figure S4B ). Correspondingly, we observed higher levels of FAK-dependent activation of MEK, ERK1/2, and the ERK substrate RSK in DIXDC1 knockdown cells ( Figure 4D ).
To further examine which pathways downstream of FAK were involved in Snail upregulation, we treated cells with small molecule inhibitors of MEK, phosphatidylinositol 3-kinase, Akt, or mTOR. Of these, only the MEK inhibitor U0126 caused complete loss of Snail protein ( Figures 4F, S4C , and S4D). This observation is consistent with previous studies reporting multiple mechanisms of ERK-dependent increases in Snail, including both mRNA induction (Barberà et al., 2004; Toettcher et al., 2013) and direct ERK phosphorylation sites in Snail suppressing protein turnover (Zhang et al., 2013) . Collectively, our findings suggest that when LKB1, MARK1, or DIXDC1 function is compromised, FAK becomes hyperactivated, resulting in MEK/ ERK-dependent induction of Snail ( Figure 4G ).
DIXDC1 Suppresses Cell Migration and Invasion in a Ser592-Dependent Manner
To examine how DIXDC1 loss impacts cell behavior, we examined cell migration and invasion. We first performed scratch assays to examine directed migration, in the presence of mitomycin C to prevent proliferation during the experiment. RNAi silencing of LKB1 or DIXDC1 resulted in increased wound healing, which was mimicked by stable overexpression of nonphosphorylatable DIXDC1
S592A , but not DIXDC1 WT (Figures 5A and 5B) . This finding suggests that in this context, DIXDC1 S592A behaves as a dominant-negative allele to suppress the activity of the endogenous DIXDC1. Increased migration upon DIXDC1 knockdown was attenuated by FAK inhibition (Figures 5C and S5A) or Snail RNAi ( Figure 5D ). To determine if DIXDC1 similarly affected invasive behavior, cells were placed in a collagen-coated Boyden chamber and allowed to invade for 24 hr prior to fixation. Cells with stable LKB1 or DIXDC1
(C) Colocalization of paxillin and zyxin in U2OS cells stably depleted for DIXDC1 by lentiviral shRNA transduction plated as described in (A). Scale bar: 10 mm. Figure 3A .
Representative images are shown. Scale bar: 10 mm, 2 mm (zoom image).
(B) Analysis of focal adhesion signaling upon plating on ECM. U2OS cells depleted of DIXDC1 by siRNA transfection (20 mM) were treated as described in Figure 3A and plated for the indicated time point. Lysates were immunoblotted with the indicated antibodies. Sus, suspension for 1 hr.
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knockdown had an $1.8-fold increase in cell invasion in that time window ( Figure 5E ). The enhanced collagen invasion of cells bearing DIXDC1 knockdown was blocked by inhibition of FAK ( Figure S5A ). (E) Collagen transwell migration assay. Transwell filters were coated with collagen I, and U2OS cells depleted for the indicated genes by siRNA transfection were plated onto filters in serum-free media supplemented with 10 ug/ml Mitomycin C for 24 hr. Filters were excised, and migrated cells were stained with DAPI and counted. ***p < 0.0001 relative to control. Statistical analysis was performed using an unpaired Student's t test.
Dixdc1 Dictates Metastatic Behavior in Non-Small Cell Lung Cancer Lines
Given the role of Lkb1 in the suppression of lung tumor metastasis in mouse Krasdependent NSCLC models (Carretero et al., 2010; Ji et al., 2007) , we wanted to explore the function of Dixdc1 in lung tumor cell lines with defined metastatic characteristics. We utilized a panel of Kras
G12D
, p53 À/À mutant lung adenocarcinoma cell lines derived from nonmetastatic and metastatic primary mouse lung tumors (T nonMet and T Met , respectively) that retain the metastatic capacity of their tumor of origin (Winslow et al., 2011) . Notably, while Lkb1 protein levels were unaffected, (legend continued on next page)
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Dixdc1 protein and mRNA levels were lower in the T Met lines compared to the T nonMet lines ( Figures 6A and S6A ), whereas Snail and FAK Phospho-Y397 levels were higher in the metastatic setting. Thus, Dixdc1 reduction and the previously observed associated biochemical signature of DIXDC1 suppression correlated with metastatic potential in these cell lines. Furthermore, stable knockdown of Dixdc1 in T nonMet cells resulted in hyperactivation of FAK signaling and increased Snail levels to an extent similar to that found in the T Met cells ( Figure 6B ).
To further investigate Dixdc1 function in these murine lung adenocarcinoma cell lines, we first confirmed that Lkb1, Mark1, and Mark4 regulate endogenous Dixdc1 Ser592 phosphorylation in the T nonMet cells ( Figure S6B ). As observed in U2OS cells, acute RNAi to Mark1 or Dixdc1 in T nonMet cells also resulted in hyperactivation of FAK upon plating ( Figure S6C ). Conversely, stable enforced expression of Dixdc1 in the T Met cells suppressed FAK signaling ( Figure S6D ). Consistent with regulation of the FAK-Snail signature, Dixdc1 knockdown in T nonMet cells resulted in increased invasion ( Figure S6E ).
To directly examine the impact of loss of Dixdc1 on metastatic potential in vivo, we stably knocked down Dixdc1 with two independent shRNAs in T nonMet cells and performed a lung colonization assay in syngeneic mice (Winslow et al., 2011) . Dixdc1 knockdown dramatically increases the lesion number and total tumor burden ( Figure 6C ), without affecting the growth rate of these cells in culture ( Figure S6F ). The increase in tumor burden in T nonMet cells observed from Dixdc1 silencing was comparable to that induced by shRNA to Lkb1 ( Figure S6G ). The increased tumor burden in the T nonMet cell lines bearing Dixdc1 shRNA was reversed by stable reexpression of a wild-type, but not S592A mutant, hDIXDC1 ( Figure 6D ). Moreover, stable expression of WT, but not S592A mutant, hDIXDC1 in T Met cells, which lack appreciable Dixdc1 ( Figures 6A and S6H ), caused potent suppression of experimental metastasis ( Figures 6E-6G ), providing strong evidence for the importance of this single phosphorylation site in governing metastasis in vivo. Quantification by luciferase imaging confirmed the decrease in total tumor burden ( Figures 6F and 6G ). The suppression of metastasis by overexpression of WT Dixdc1 also demonstrates that the T Met cells are capable of receiving Lkb1-dependent signals to Dixdc1 but simply lack sufficient Dixdc1 expression as compared to the nonmetastatic cells.
DIXDC1 Is Frequently Lost in Human Cancers
Though the T Met cell lines retain Lkb1, given their loss of Dixdc1 mRNA expression and potent effects of Dixdc1 on tumor burden in this setting, we wondered whether DIXDC1 may be deleted, mutated, or downregulated in human tumors. We examined copy number variations for human DIXDC1, which lies in a broad tumor suppressor region on chromosome 11q23.1. GISTIC analysis reveals that DIXDC1 is significantly deleted in 11 out of 27 cancer subsets across the entire Tumorscape/TCGA data set of 9,041 tumors. Notably, DIXDC1 is most significantly deleted independent of a peak region in metastatic cutaneous melanoma, lung cancer, and cervical squamous cell carcinoma (Figure 7A ). Although infrequent, we were able to observe patient samples that displayed a focal, highly specific deletion at the DIXDC1 locus ( Figure 7B ). Interestingly, melanoma, lung cancer, and cervical carcinoma represent well-defined settings where loss of Lkb1 in GEMMs modulates metastasis and FAK/Src signaling (Liu et al., 2012) . In support of this analysis, using an algorithm (CONEXIC) that combines gene expression and copy number alterations to identify driver events in melanoma, suppression of DIXDC1 was identified as one of the top 30 drivers in this tumor type (Akavia et al., 2010) . Importantly, DIXDC1 mRNA expression correlated better with global gene expression changes than any of the other 16 genes in a focal deletion region of 11q23.1 or the focal deletion of 11q23.1 itself (Akavia et al., 2010) , reinforcing that alterations in DIXDC1 mRNA levels are a critical measure of its functionality beyond the subset of tumors bearing LKB1 mutations where DIXDC1 is inactivated from loss of Ser592 phosphorylation.
Analysis of DIXDC1 mRNA expression in human NSCLC cancer data sets revealed its frequent downregulation ( Figures S7A-S7D ). Interestingly, Dixdc1 was previously identified as one of only 97 genes genome-wide that were cooperatively suppressed at the mRNA level by Kras and p53 mutation in a pattern correlating with the malignant phenotype (Figure S7E) . The 97 genes identified in this data set proved relevant across a broad panel of human tumor cell lines, suggesting they may be relevant for tumorigenesis across cell contexts. To (C) Lung colonization assay. T nonMet 368T1 cells were stably depleted of endogenous Dixdc1 by lentiviral transduction with two independent shRNA sequences. Cells were then injected intravenously in the lateral tail vein of syngeneic 129/Bl6 F 1 mice. Lungs were harvested 3 weeks posttransplantation, and representative hematoxylin & eosin (H&E)-stained sections are shown. Total lung tumor burden was quantified using morphometric Inform software. Scale bar: 1 mm (top image), 100 mm (zoom image). Statistical analysis was performed using an unpaired Student's t test. (D) Rescue of enhanced colonization efficiency by enforced expression of WT, but not S592A mutant hDIXDC1 in T nonMet cells. Cells were stably depleted for endogenous Dixdc1 or GFP control by lentiviral shRNA transduction. Knockdown cells were then reconstituted with a WT or S592A hDIXDC1 cDNA using retroviral transduction. Stably selected cells were injected intravenously, and colonization efficiency was assessed by H&E staining 3 weeks posttransplantation. Total lung tumor burden was quantified using morphometric Inform software. Scale bar: 1 mm (top image), 100 mm (zoom image). Statistical analysis was performed using an unpaired Student's t test. (E) Suppression of lung colonization by highly metastatic T Met 393T5 cells through enforced expression of WT, but not S592A mutant hDIXDC1. T Met 393T5 cells, which express low levels of Dixdc1 (A), were transduced with a retroviral vector encoding the cDNA for WT or S592A mutant hDIXDC1. Cells were transduced with a lentiviral vector expressing firefly luciferase and subsequently injected intravenously in the lateral tail vein of syngeneic 129/Bl6 F 1 mice. Representative H&E sections of mouse lungs at 3 weeks posttransplantation are shown. Scale: 1 mm. (F) Quantification of total bioluminescence at 3 weeks (E) compared to 30 min post-tumor cell intravenous transplantation. **p < 0.001 unpaired Student's t test. N.S., not significant. (G) At 3 weeks posttransplantation, mice from (E) (n = 5/group) were imaged using IVIS bioluminescence imaging. Signal intensity representing lung tumor burden is shown. All data are represented as the mean ± SEM.
(legend on next page)
further explore DIXDC1 expression in human cancer, we next examined DIXDC1 levels as a function of patient outcome in an annotated set of NSCLC tumors. Mining a recent meta-analysis of published lung cancer microarray data sets that identified biomarkers related to survival (Gy} orffy et al., 2013), we found that low DIXDC1 expression in lung adenocarcinoma patients is significantly correlated with decreased progression-free and overall survival ( Figure 7C ). As survival in such cohorts is largely due to metastasis, this suggests that in these contexts low DIXDC1 mRNA may correlate with increased metastatic frequency.
DISCUSSION
In this study, we identified the poorly studied scaffold protein DIXDC1 as a direct substrate of LKB1-dependent kinases connected to metastatic progression. Phenotypes observed from gain and loss of DIXDC1 function also help provide a direct molecular basis for the only previously noted biomarkers of Lkb1-deficient metastasis: (1) hyperactivation of FAK/Src family kinase signaling (Carretero et al., 2010; Liu et al., 2012) and (2) increased expression of some EMT target genes (Carretero et al., 2010) . This effect is mediated by MARK1/4-dependent activation of DIXDC1, which suppresses the FAK-ERK-Snail1 signaling axis ( Figure 7D ). While MARK1 and MARK4 do not appear redundant in the regulation of DIXDC1, it remains unclear whether this reflects their formation of a heterodimeric complex or alternative possibilities to be pursued in future studies. Phosphorylation of DIXDC1 at Ser592 by MARK1/4 is required for its proper targeting to focal adhesions and required for DIXDC1 to suppress metastatic growth in vivo. In addition to the functional inactivation of DIXDC1 in LKB1 À/À tumors from loss of Ser592 phosphorylation, we found that deletions at the DIXDC1 locus were highly selected for in the exact tumor subsets where LKB1 has been characterized as a dominant regulator of metastasis. It is also worth noting that few endogenous suppressors of EMT are known, which may explain why DIXDC1 downregulation would be selected for independent of LKB1 mutation, as its loss promotes Snail-dependent gene expression, stimulating invasion and tumor microenvironment remodeling. Analysis of DIXDC1 and its regulation by other pathways that modulate EMT will be of great interest, in the context of both different tumor types and developmental processes. Molecularly, our data suggest that DIXDC1 is involved in focal adhesion maturation. We observed that loss of DIXDC1 results in an accumulation of nascent focal adhesions, which were largely absent for zyxin staining. Zyxin null cells display increased rates of cell motility as well as hyperactivation of the FAK/Src signaling module (Hoffman et al., 2006; Mise et al., 2012) , consistent with the phenotypes we observe with zyxin mislocalization in DIXDC1-depleted cells. In a broad context, downregulation of factors that regulate the maturation of focal adhesions such as DIXDC1 and zyxin might be selected for in those cells gaining increased invasion potential. How does this role for DIXDC1 in suppressing cell migration and invasion fit with the few previously reported functions for DIXDC1? Previous studies identified Nudel and Dvl proteins as the predominant in vivo DIXDC1 interaction partners (Shiomi et al., 2003; Singh et al., 2010; Wong et al., 2004) , which interestingly have both been reported to regulate cell motility and focal adhesion dynamics via effects on FAK and paxillin (Matsumoto et al., 2010; Shan et al., 2009) . We have confirmed DIXDC1 association with endogenous Nudel and Dvl, though we have not been able to detect their association with FAK or paxillin thus far. Future studies will be aimed at identifying a DIXDC1 interaction network during adhesion and focal adhesion maturation to better define how it suppresses FAK signaling. The central involvement of FAK in LKB1-dependent metastatic potential fits well with emerging evidence that hyperactivation of FAK and Src may represent a central biochemical pathway broadly required for metastasis in tumors from many different tissues of origin (Shibue and Weinberg, 2009; Zhang et al., 2009 ). This study suggests that certain initiating genetic alterations may provide robust metastatic fitness by activating FAK/SRC from even early stages of tumorigenesis, alleviating the need for additional genetic lesions to enhance metastatic potential.
Notably, phosphorylation of DIXDC1 downstream of LKB1 is mediated by the poorly studied kinases MARK1 and MARK4 and independent of AMPK. DIXDC1 represents one of the first AMPK-independent effectors of LKB1 in human cancer and indicates that in some contexts the tumor suppressor activity of LKB1 is unlikely to be mediated by AMPK alone. The finding that LKB1 actively suppresses the Snail1 EMT transcription factor through a signaling pathway downstream of MARK1 and MARK4 suggests that much remains to be decoded for this ancient pathway connecting metabolism to cell polarity and cytoskeletal control. This study also provides further molecular insight into how initiating mutations in the LKB1 tumor suppressor leads simultaneously to immediate alterations in mTOR signaling, autophagy, metabolism, as well as FAK signaling (the latter via loss of phosphorylation of a single serine residue in a single downstream effector). Regulation of such seemingly diverse cell processes by LKB1 may underlie its unique potency for tumor initiation and (B) Lung adenocarcinoma patients exhibiting a deletion at the DIXDC1 locus were visualized using the Integrative Genomic Viewer (IGVv2.3; Broad Institute). Blue bars represent the degree of deletion, white bars represent no alteration, and red bars represent an amplification. DNA copy number ratio is relative to a reference somatic DNA sample. Note the single patient representing a focal deletion at the DIXDC1 locus. (C) Correlation of DIXDC1 expression with patient survival in lung adenocarcinoma. DIXDC1 expression was stratified as high versus low against median expression. Overall survival and progression-free survival within previously published data sets were analyzed using the kmPlotter (www.kmplot.com). (D) Model. LKB1, functioning through the downstream kinases MARK1 and MARK4, positively regulates DIXDC1 to promote focal adhesion maturation and suppress cell migration, invasion, and metastatic potential. Upon loss of LKB1-dependent phosphorylation, or upon downregulation or deletion of the DIXDC1 gene as occurs in human cancer, focal adhesions become more dynamic, and resident kinases FAK/Src activate a signaling cascade through ERK to induce the EMT transcription factor Snail. Expression of Snail drives genes associated with invasion and migration. metastatic progression in some tissues, and warrants further investigation into identifying the full repertoire of conserved substrates of the LKB1-dependent kinases to reveal additional ratelimiting regulators of cell biology and disease.
EXPERIMENTAL PROCEDURES
Plasmid Constructs
The cDNA for human DIXDC1 was cloned from a cDNA library prepared from U2OS cells and sequence verified to match the sequence of the long isoform of human DIXDC1 (NM_001037954.2). DIXDC1 cDNA was subcloned into pENTR4-FLAG (Addgene #17423) or pENTR4-myc (edited from pENTR4-FLAG) to create FLAG-or myc-tagged ENTR clones, respectively. ENTR clones for human LKB1 and LYK5 (STRADalpha) were obtained from Invitrogen (IOH21169 and IOH45129, respectively). Human Snail cDNA (Addgene #16218) and Slug cDNA (Addgene #31698) were PCR amplified and subcloned to pDONR221 with BP Clonase (Invitrogen). Site-directed mutagenesis was performed using QuikChange II XL (Stratagene) according to the manufacturer's instructions. All ENTR/DONR clones were sequence verified to ensure no additional mutations. To create mammalian expression vectors, ENTR clones were recombined into DEST vectors using LR Clonase (Invitrogen). DEST vectors used in this study include the following: pQCXIB (Addgene #17400), pQCXIN (Addgene #17395), pLentiCMV/TO DEST (Addgene #17293), pcDNA3 N-term myc DEST, pcDNA3 N-term FLAG DEST, and pBabe-Hygro DEST. pEBG2T-hMARK1 WT and T215A(KD) were a gift from Dario Alessi (Dundee, UK).
Antibodies
The following Cell Signaling Technology antibodies were used: Wnt5a/b (#2530), Snail (#3879), Slug (#9585), ZEB1 (#3396), LKB1 (#3047), P-ACC S79 (#3661), Total ACC (#4190), Axin2 (#2151), MARK2 (#9118), MARK3 (#9311), AMPKalpha (#2532), P-ULK1 S555 (#5869), Nuak1 (#4458), SIK2 (#6919), GST (#2622), myc-tag (#2272), P-Src family Y416 (#2113), Src (#2109), P-Paxillin Y118 (#2541), Pathscan I for P-ERK1/2 and P-Akt S473 (#5301), Total ERK1/2 (#4695), P-S6K (#9234), HA-tag (#3724), P-MEK1/2 (#9154), P-p90RSK S380 (#11989), and P-FAK Y925 (#3284). The following Epitomics antibodies were used: Phospho-FAK Y397 (#2211-1), Phospho-FAK Y576/577 (#2183-1), Total FAK1 (#2146-1), and Zyxin (#3586-1). The following BD Transduction Labs antibody was used: Paxillin (P13520). The following Sigma antibodies were used: Actin (A5441) and Flag polyclonal (F7425). The following Protein Tech antibodies were used: MARK1 (21552-1-AP) and MARK2 (15492-1-AP). The following Millipore antibodies were used: ZEB2 (ABT332) and MARK4 (07-699). The following Abcam antibodies were used: Twist (ab50887) and IRSp53 (ab15697). CLASP2 antibody was from Santa Cruz Biotechnology (sc-98440). DIXDC1 total antibody was from R&D Systems (AF5599). Phospho-DIXDC1 S592 was developed in collaboration with Antony Wood at Cell Signaling Technologies.
Cell Lines U2OS, H157, H1299, SJSA, Panc-1, MiaPaca-2, and 293T were purchased from ATCC. Littermate-derived Lkb1 +/+ and Lkb1 À/À MEFs were described previously (Shaw et al., 2004) . T nonMet and T Met primary mouse lung cancer cell have been described previously (Winslow et al., 2011) . Specific lines used in this study include 368T1, 394T4, 802T4, 565T2, and 393T5. All cells were maintained in Dulbecco's modified Eagle's medium (Mediatech) supplemented with 10% fetal bovine serum (Hyclone, Thermo Scientific) and cultured at 37 C in 10% CO 2 .
Animal Studies Tumor lysates from Kras
G12D
;Lkb1 +/+ and Kras
;Lkb1 À/À primary lung tumors were generated from Lox-Stop-Lox Kras G12D and Lkb1 flox/flox mice as previously described (Shackelford et al., 2013) . Mice used for syngeneic mouse transplantation assays were 129/Bl6 F 1 hybrid mice (The Jackson Laboratory) as described previously (Winslow et al., 2011) . Mice were 7-9 weeks old at the time of injections. For lung colonization assays, 7 3 10 4 cells resuspended in 200 ml PBS were injected through the lateral tail vein. Mice were sacrificed 3 weeks after injection, and lungs were harvested for tissue processing. All experiments were conducted in accordance with the guidelines of the Association for Assessment and Accreditation of Laboratory Animal Care International and after approval of the institutional care and use committee for animal research at the Salk Institute. imager, and the data were normalized so that the average value at a given position was equal to 1. Heat maps show log transformed data (average value in each position is zero). MARK family members are highly similar in preferred consensus phosphorylation motif.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
(B) Workflow of screen to identify conserved MARK kinase substrates starting with bioinformatics analysis using optimal consensus phosphorylation motifs. Scansite and Phosphosite databases were mined for proteins containing a preferred sequence. Site conservation across evolution used to increase likelihood of functional phosphorylation sites. This screening approach identified numerous known MARK substrates as well as many novel candidates, including a group with Pfam domain annotation or GO term annotation as playing a role in cytoskeleton. Functionally screening of 25 candidates revealed 8 potential in vivo MARK substrates. Sequence alignments and domain structures of the putative MARK substrates illustrating the location of the consensus phosphorylation motif are displayed.
(C) GST-14-3-3 binding assay. MARK1 WT or T215A (KD) was co-transfected with FLAG-IRSp53, a known MARK substrate that binds 14-3-3, in HEK 293T cells. Cleared lysates were subjected to pull down with 5 μg of recombinant GST or GST-14-3-3 for 2 hr. GST was then captured using GSH-sepharose beads for 1 hr. Immunoprecipitates were immunoblotted for FLAG-IRSp53.
(D) GST-14-3-3 binding assay as described in (C) with co-transfection of FLAG-DIXDC1.
(E) Deconvolution of DIXDC1 SmartPOOL siRNA oligos. Pooled oligos (SP) and individual pool component oligos (20 μM final) were transfected into U2OS cells for 72 hr. Lysates were immunoblotted for Snail protein induction.
(F) GST-14-3-3 binding assay described in (C) examining co-transfection of MARK1 WT with either FLAG-
DIXDC1-WT or FLAG-DIXDC1-S592A (S-A).
(G) In vitro-IP kinase assay using recombinant Active MARK4 as described in Fig. 2D . (A) U2OS cells were transfected with RNAi oligos (20 μM) for 72 hr. Cells were serum-starved overnight and plated as in Fig. 3A . Cells were pretreated for 3 hr with 1 μM PF-573228 prior to being placed in suspension. Upon plating onto collagen I coated plates, 1 μM PF-573228 was added for the 1 hr duration.
Lysates were immunoblotted with the indicated antibodies. Sus = Suspension 1 hr.
(B) U2OS cells were transfected with siRNA against DIXDC1 (20 μM) for 48 hr. Cells were then serumstarved for 24 hours prior to cell lysis. Endogenous GRB2 was immunoprecipitated using a GRB2 antibody and immunoblotted for FAK and Src binding. (E) Matrigel transwell invasion assay. T nonMet cells stably depleted for Dixdc1 or GFP control used in Fig. 6B were plated in the absence of serum in the upper chamber of a matrigel coated transwell apparatus. Cell invasion was quantified 24 hr post plating using crystal violet dye elution. *** p < .0001 relative to shGFP.
Statistical analysis performed using an unpaired Student's t-test.
(F) MTT growth assay comparing proliferation rates of T nonMet shGFP and shDixdc1 cells from Fig. 6B . p > 0.9 using unpaired Student's t-test.
(G) Lung colonization assay comparing stable shRNA depletion of Lkb1 to Dixdc1. T nonMet 368T1 cells infected with indicated shRNA lentiviral vectors were injected intravenously and lung colonization ability was assessed at 3 weeks post transplantation by H&E staining. Scale = 1mm.
(H) Expression levels of DIXDC1 in retrovirally transduced T Met 393T5 cells used in Fig. 6F . were made with the defined oncogenic perturbations followed by microarray analysis. Raw expression values are displayed for Dixdc1 across the cell populations. * p < .05, *** p < .001.
EXTENDED EXPERIMENTAL PROCEDURES
RNA extraction and qPCR analysis
Total RNA was extracted using Trizol (Invitrogen) according to the manufacturers protocol. RNA was treated with DNase I (New England Biolabs, MA). cDNA amplification was performed using the High Capacity Reverse Transcription Kit (Applied Biosystems). qPCR primers were designed using Primer 3 MIT software and sequences were chosen that spanned exon junctions. Seqeunces are listed below 5' to 3'.
The pLKO-based shRNA plasmids were obtained from the TRC Collection (Sigma-Aldrich, St. Louis, MO).
Gene names and TRC numbers are listed below.
hPTK2 #10 TRCN0000196310 hPTK2 #37 David Schlaepfer Lab (Lim et al., 2008) "X2" designation above indicates that hairpin sequences were ordered from IDT DNA Services (San Diego, CA) and subsequently subcloned into pENTR/pTER+ or pENTR/pSuper+ according to Eric Campeau Lab cloning protocol (http://www.ericcampeau.com/manuals.html). ENTR-shRNA constructs were recombined into the pLentiX2 series of plasmids also obtained from the Eric Campeau lab through Addgene (Campeau et al., 2009) . shRNA targeting GFP was also obtained from Eric Campeau lab through Addgene (shEGFP#1 sequence Addgene #17470).
Custom shRNA were designed using Block-IT RNAi Designer (Invitrogen). Custom sequence for hDIXDC1
3'utr hairpin listed below:
shDIXDC1 Human 3'utr 5'-GCATCATTCCTGTGTGTTAGTGTGCTGTCCTAACACACAGGAATGATGCTTTTT 
Reagents and Chemicals
Transfection and Virus Production
For transient expression of proteins and packaging of virus, HEK293T cells were transfected with DNA or short hairpin RNA (shRNA) plasmids using Lipofectamine 2000 (Invitrogen, Carlsbad, CA) following the manufacturer's protocol. Lentiviral shRNA transduction and retroviral gene expression was performed as described previously (Gwinn et al., 2008) . Briefly, for retroviral infection, the pQCXIN or pQCXIB constructs were transfected along with the pCL-Ampho packaging plasmid into growing, low-passage HEK293T cells. Virus containing supernatants were collected 48 hours after transfection, centrifuged, and syringe-filtered to eliminate residual HEK293T cells. Viral transduction was performed for 16 hours in the presence of polybrene (8 ug/ml). Selective antibiotic was applied 24 hours after transduction. For lentiviral shRNA knockdown, hairpin sequences were either used as supplied in the pLKO vector backbone (TRC Collection, Sigma) or subcloned into the pENTR/pSUPER+ or pENTR/pTER+ entry cassettes (Addgene #17338 or Addgene #17453, respectively). shRNA sequences driven by the H1 promoter were then recombined in the pLentiX2
series of viral vectors (Addgene #17296 and #17390). The shRNA-containing vectors were transfected into HEK293T cells with lentiviral packaging plasmids vsvg, GAG/pol, and REV using Lipofectamine 2000. Viruses were collected 48 hours after transfection, and target cells were infected for 16 hours to achieve depletion of endogenous proteins.
Migration and Invasion Assays
For migration analysis, scratch wounds were made to a confluent monolayer to stimulate direction cell migration. Briefly, cells were plated to confluency in 35mm plates and then scratched with P10 pipette tips.
Monolayers were washed 4 times with PBS and then fresh media was added. Cells were allowed to migrate to close the wound in the presence of Mitomycin C (10 μg/ml) for 12-16 hrs. Cells were then fixed with 4%
paraformaldehyde/PBS for 10 min at room temperature and subsequently stained with rhodamine-labelled Phalloidin (Invitrogen/Molecular Probes; 1:200) to distinguish cell boundaries (Simpson et al., 2008) .
For invasion assays, cells were plated into matrigel-coated transwell inserts and invasion assays were carried out according to the manufacturers protocol. Briefly, 10 5 cells were plated in serum free media in the upper chambers of equilibrated matrigel-coated transwell inserts. Inserts were then placed into wells containing media with 10% FBS as a chemoattractant. Cells were then incubated for 24-48 hours to allow invasion. Inserts were then fixed and stained with crystal violet stain solution (0.5% crystal violet, 0.5% formal saline, 145 mM NaCl, 50% EtOH) and cells remaining in the upper chamber were removed with a cotton swab. Crystal violet dye was eluted from invaded cells on the bottom of the insert in 33% acetic acid and absorbance was quantified using a microplate reader with a 562nm ref 650nm absorbance. In Figure   5B , membranes were first cleared of cells remaining in the upper chamber, then excised from the transwell insert and stained with DAPI. Number of migrated cells/field was counted for 8 fields/membrane.
Immunofluorescence
Cells were plated on collagen-coated glass coverslips for the indicated timepoints and then fixed in 4% paraformaldehyde/PBS for 10 minutes at room temperature followed by permeabilization in 0.2% Triton X-100/PBS for 10 minutes. Cells were then blocked with 3% BSA/PBST and subsequently incubated with All confocal microscopy was performed on an LSM 710 spectral confocal microscope mounted on an inverted Axio Observer Z1 frame (Carl Zeiss, Jena, Germany) as previously described . Colocalization analysis was performed using ImageJ with the PSC colocalization plugin (French et al., 2008) . Briefly, region of interests were created around peripheral adhesions of immunostained cells (4-6 regions/cell). Pearson's coefficient of colocalization was then determined using the PSC plugin. 10-20 cells were analyzed per condition and box-whisker plots were generated representing the Pearson's coefficients across each sample.
In vitro Kinase Assay
Recombinant active MARK1 and MARK4 were purchased from Sigma (M8447 and SRP5046, respectively) and kinase assays were carried out according to manufacturers protocol. Briefly, WT or S592A mychDIXDC1 was immunoprecipitated from transiently transfected HEK293T cells. Immunoprecipitates were washed three times in IP buffer followed by two washes in kinase buffer (25mM MOPS pH 7.2, 12.5mM
glycerol-2-phosphate, 25 mM MgCl 2 , 5 mM EGTA, and 2mM EDTA). Immunoprecipitates were then incubated with or without 15ul of active MARK1 or MARK4 under recommended reaction conditions in 100μl final volume, using cold ATP. Reactions were then boiled and run out on SDS-PAGE gel. Phosphorylation of DIXDC1 was detected with a P-DIXDC1 S592 specific antibody (CST).
Peptide library screening
Peptide mixtures (50 μM) were incubated 2 hours at 30 ºC in multiwell plates in the presence of the indicated kinase in 50 mM HEPES, pH 7.4, 25 mM MgCl2, 0.25 mM DTT, 12.5 mM β-glycerophosphate, 5 mM EGTA, 2 mM EDTA, 0.1% Tween 20, and 50 μM ATP (0.03 μCi/ml). Aliquots of each reaction were transferred to streptavidin-coated membrane (Promega), which was quenched, washed and dried as described previously (Hutti et al., 2004) . Membranes were exposed to a phosphor imager screen to quantify radiolabel incorporation. Heat maps were generated using Microsoft Excel.
MARK substrate screen
To identify substrates of the MARK kinases, we determined the optimal substrate motif for all four MARK family members using arrayed positional scanning peptide libraries. First, we bioinformatically queried the human proteome to identify proteins containing candidate phosphorylation sites matching the optimal MARK substrate motif using the ScanSite (scansite3.mit.edu) and ProSite (http://prosite.expasy.org/) databases.
Proteins with consensus motif matches were further queried using the PhosphoSite (www.phosphosite.org) database for existing evidence of in vivo phosphorylation. Site conservation was examined across evolution using UniProt (www.uniprot.org) and NCBI PubMed Protein databases. Additional stringency was achieved by re-performing the search on other eukaryotic genomes allowed us to narrow the initial ~1000 candidate human substrates to ~300 highly conserved candidate substrate sites. Given that control of the cytoskeleton is a major conserved function of the MARK/Par1 kinase family, we focused our attention on 25 candidate MARK substrates bearing conserved phosphorylation motifs that contained a Pfam domain indicative of a role in cytoskeleton or were classified by gene ontology (GO) as having a role in cytoskeletal signaling.
To test of whether these 25 candidates may be regulated by the MARK kinases, we used two approaches.
We examined substrate phosphorylation by exogenous gain and loss of function of MARK1 kinase activity either indirectly through regulated binding of the substrate to the phospho-dependent binding scaffold protein 14-3-3, or directly by reactivity with phospho-motif antibodies generated against peptides overlapping with the optimal MARK substrate motif (CST #5759, #9606, #9601, and #4381). In the first approach, the 25 candidates cDNAs were cloned into an epitope-tagged mammalian expression construct and then were co-expressed in HEK293T cells with wild-type or kinase-dead MARK1. Cells were lysed in IP buffer, followed by addition of 5 μg of GST or GST-14-3-3 to cell extracts and incubation at 4 degrees for 2 hr with gentle rocking. Complexes were precipitated with the addition of gluthathione sepharose at 4 degrees for 1 hr. This assay reveals direct substrates that associate specifically with GST-14-3-3 only when the wild-type, but not kinase-dead, AMPKR is co-expressed. As half the known AMPKR substrates do not interact with 14-3-3 upon phosphorylation, our second approach was to examine whether exogenous MARK1 activity would regulate recognition of the substrate by phospho-motif antibodies. Here candidate substrate cDNAs in an epitope-tagged mammalian expression construct are co-expressed in HEK293T cells with wild-type or kinase-dead MARK1, then immunoprecipitated with the tag antibody and immunoblotted with the phospho-motif antibody. Of note, both of these approaches are based on co-overexpression of both the candidate substrate and the MARK kinases, so positive results here indicate that the phosphorylation event is possible in cells, but does reflect whether the endogenous candidate substrate is targeted by the endogenous AMPKR kinase when each are expressed at their endogenous levels and localized appropriately, which requires additional experimentation.
Cell Lysis, Immunoblotting, and Immunoprecipitation
Cells were lysed at indicated timepoints in lysis/IP buffer (20 mM Tris (pH 7.5), 150 mM NaCl, 1 mM EDTA, 1mM EGTA, 1% Triton X-100, 2.5 mM pyrophosphate, 50 mM NaF, 5 mM β-glycero-phosphate, 50 nM calyculin A, 1 mM Na 3 VO 4 , 10 mM PMSF, 4 mg/ml leupeptin, 4 mg/ml pepstatin, 4 mg/ml aprotinin). Total protein was normalized using BCA protein kit (Pierce Protein, Rockford, IL) and lysates were resolved on SDS-PAGE gel.
Immunoprecipitations were performed on equilibrated protein lysates. Briefly, primary antibody was added to cleared cell lysates and incubated at 4°C on a rocking platform for 2 hours. Antibody complexes were then captured with the addition of Protein G-Sepharose beads (Invitrogen, Carlsbad, CA) for 1 hour.
Immunoprecipitates were then washed 3 times in lysis buffer and samples were boiled and run on SDS-PAGE gels. Primary antibodies used for immunoprecipitation: mouse anti-FLAG M2 (Sigma), or mouse antimyc 9E10 ascites fluid (gift from laboratory of Dr. Tony Hunter).
Recombinant GST-14-3-3 binding assay
Recombinant GST or GST-14-3-3 were produced in E. coli as previously described (Yaffe et al., 1997 ) then purified on glutathione sepharose and eluted with free glutathione. MARK1 WT or MARK1 T215A along with the indicated FLAG-tagged substrate of interest was transfected into HEK 293T for 18 hr using Lipofectamine 2000. Cells were lysed in IP buffer, followed by addition of 5 μg of GST or GST-14-3-3 to cell extracts and incubation at 4 degrees for 2 hr with gentle rocking. Complexes were precipitated with the addition of gluthathione sepharose at 4 degrees for 1 hr.
RNAi transfection and oligos
RNAi mediated gene depletion was carried out by reverse transfection of siRNA oligos using RNAiMAX (Invitrogen) according to manufacturers protocol. siRNA duplexes were used at 20 nM unless otherwise noted. Negative universal control was from Invitrogen (Medium GC content). ON-TARGET SmartPOOL RNAi against hLKB1, hPRKAA1, hPRKAA2, hMARK1, hMARK2, hMARK3, hMARK4, hNUAK1, hNUAK2, hSIK1, hSIK2, hAPC, hDIXDC1, hBAIAP2, hCLASP1, hCLASP2, hKIF13B, hPARD3, hMAP4, mDixdc1, hCK1epsilon, hWNT5A, hWNT5B, hSNAI1 , and mSnai1 were obtained from Dharmacon Thermo Scientific.
Cells were harvested at 72 hours post siRNA transfection or further manipulated in functional assays.
Adhesion and replating experiments
To analyze activity of tyrosine kinases present at focal adhesions, cells were stimulated by plating onto extracellular matrix coated dishes as previously described (Bernard-Trifilo et al., 2006) . Briefly, cells were serum-starved the night previous to plating experiments. Cell culture dishes were coated with rat tail Collagen I (BD) in sterile water for 2 hours at 37°C. Collagen solution was aspirated off and dishes were allowed to dry for 30 min in a sterile hood. Serum-free DMEM was then added to coated plates and allowed to equilibrate for 30 min at 37°C. Meanwhile, cells were trypsinized, centrifuged, and resuspended at equal cell density in serum-free DMEM. Cells were kept in suspension for 1 hr to synchronize focal adhesion formation. After 1 hr, cells were plated onto equilibrated collagen-coated dishes and incubated for the indicated timepoints.
To inhibit focal adhesion kinase (FAK) activity using the chemical inhibitor PF-573228 (Fig. S4A ), cells were exposed to the inhibitor (1 μM) for 3 hours prior to cell suspension and also replated in the context of the inhibitor (1 μM) for 1 hour on collagen-coated plates.
Mouse Bioluminescent Imaging
Bioluminescent imaging was performed on mice using Total change in BLI was determined by normalizing signal at 3 weeks to signal at 30 minutes for each mouse.
Histology and Quantitation of lung tumor burden using Nuance/Inform software
Mouse tissues were perfusion fixed in 10% neutral buffered formalin overnight, processed routinely and embedded in paraffin. Four μM thick sections from formalin fixed paraffin embedded (FFPE) lung tumors were cut and stained with hematoxylin and eosin (H&E). Lung tumor burden was determined by histological analysis of tumor area. H&E stained lung sections were imaged using a Zeiss Axio Imager.M2 and the Nuance FX multispectral imaging system (Cambridge Research and Instrumentation, Cambridge, MA).
Whole cross sections of lungs were imaged at 1.25X magnification. Images were converted to digital image cubes and spectral libraries were made for Hematoxylin and Eosin (H&E). H&E stained whole lung sections were imaged and spectrally unmixed then pseudo-colored and the pixel counts were quantified using by averaging the total pixel count for each mouse in the treatment group.
Bioinformatics
In order to identify candidate MARK substrates, the optimal MARK motif was queried in the ScanSite (scansite3.mit.edu) and ProSite (http://prosite.expasy.org/) databases. Proteins with consensus motif matches were further queried using the PhosphoSite (www.phosphosite.org) database for existing evidence of in vivo phosphorylation. Site conservation was examined across evolution using UniProt (www.uniprot.org) and NCBI PubMed Protein databases.
mRNA expression analysis of DIXDC1 in human lung cancer datasets was performed using Lung Cancer
Explorer (UTSW QBRC/CCBSR; qbrc.swmed.edu/lce/). Studies represented are referenced in the main text. Graphs in supplemental Figure S7D -F were generated through curation of publicly available datasets on the NCBI GEO Omnibus using the GEO2R viewer. Datasets analyzed in this study include GSE7670, GSE19188, GSE9199. Profile graphs were obtained using the Affymetrix gene probe-set ID number for DIXDC1 on the given array platform. Mapping of DIXDC1 copy number alterations was done using
TumorScape platform encompassing the TCGA databases (Broad Institute; www.broadinstitute.org/tcga).
DIXDC1 was significantly focally deleted across the entire tumor dataset of 3131 tumors, with significance being reached in the displayed tumor types (q-value < 0.25). To determine the minimal common region, we used the Integrative Genomic Viewer (IGV, Broad Institute) to sort the samples by deletion of DIXDC1, and then defined the smallest deletion that encompassed the DIXDC1 locus.
Correlation of DIXDC1 expression levels to patient survival in non-small cell lung cancer was done using the KMplotter (kmplot.com; (Gyorffy et al., 2013) . Patients were split by median DIXDC1 expression, and analysis was performed the lung adenocarcinoma dataset irrespective of grade, stage, or prior treatment regimen. OS = Overall Survival. PFS = Progression Free Survival.
